Literature DB >> 27928551

Drug Discrimination and the Analysis of Private Events.

Brian D Kangas1, David R Maguire2.   

Abstract

A defining feature of radical behaviorism is the explicit inclusion of private events as material phenomena within a science of behavior. Surprisingly, however, despite much theorizing, there is a notable paucity within behavior analysis of controlled experimentation and analysis of private events, especially in nonhuman animals. One technique that is amenable to the study of private events is drug discrimination. For over 40 years, drug discrimination procedures have been an incredibly effective tool providing a wealth of in vivo pharmacological information about drugs including receptor selectivity, potency, and efficacy. In addition, this procedure has provided important preclinical indications of abuse liability. However, despite its prowess as a pharmacologic tool, or perhaps because of it, empirical investigation of its parameters, procedural elements, and variants is not currently an active research domain. This review highlights the drug discrimination procedure as a powerful means to systematically investigate private events by using drugs as interoceptive stimuli. In addition to the opportunity to study privacy, empirical evaluation of the drug discrimination procedure will likely inform and improve the standard practice for future endeavors in basic and clinical pharmacology.

Entities:  

Keywords:  behavioral pharmacology; drug discrimination; private events; radical behaviorism

Year:  2016        PMID: 27928551      PMCID: PMC5137942          DOI: 10.1037/bar0000032

Source DB:  PubMed          Journal:  Behav Anal (Wash D C)        ISSN: 2372-9414


  57 in total

Review 1.  Specious reward: a behavioral theory of impulsiveness and impulse control.

Authors:  G Ainslie
Journal:  Psychol Bull       Date:  1975-07       Impact factor: 17.737

2.  Naltrexone discrimination in morphine-treated monkeys.

Authors:  C P France; J H Woods
Journal:  NIDA Res Monogr       Date:  1989

3.  Evaluation of the discriminative effects of morphine in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

4.  An animal model of the interpersonal communication of interoceptive (private) states.

Authors:  D Lubinski; T Thompson
Journal:  J Exp Anal Behav       Date:  1987-07       Impact factor: 2.468

5.  Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15-1788) after 7 days of diazepam.

Authors:  S E Lukas; R R Griffiths
Journal:  Science       Date:  1982-09-17       Impact factor: 47.728

6.  Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.

Authors:  Jennifer L Stewart; Lance R McMahon
Journal:  J Pharmacol Exp Ther       Date:  2010-04-07       Impact factor: 4.030

7.  Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.

Authors:  M Picker; L A Dykstra
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

8.  The rise (and fall?) of drug discrimination research.

Authors:  Lance R McMahon
Journal:  Drug Alcohol Depend       Date:  2015-06-01       Impact factor: 4.492

9.  Discriminative stimulus effects of naltrexone in the morphine-dependent rat.

Authors:  V F Gellert; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1979-12       Impact factor: 4.030

10.  Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.

Authors:  J R Traynor; S R Nahorski
Journal:  Mol Pharmacol       Date:  1995-04       Impact factor: 4.436

View more
  2 in total

1.  Developing Improved Translational Models of Pain: A Role for the Behavioral Scientist.

Authors:  Sarah L Withey; David R Maguire; Brian D Kangas
Journal:  Perspect Behav Sci       Date:  2020-01-03

Review 2.  The instrumental role of operant paradigms in translational psychiatric research: Insights from a maternal immune activation model of schizophrenia risk.

Authors:  Ashley R Deane; Ryan D Ward
Journal:  J Exp Anal Behav       Date:  2022-03-23       Impact factor: 2.215

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.